StockClub
ZVRAZevra Therapeutics, Inc.$ --
Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc.

ZVRA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
36M USD
YoY +77.5%
Operating Income
9M USD
YoY +264.7%
Net Income
38M USD
YoY +1322.7%
EPS
0.62$
YoY +1182.0%

Revenue

$36.2M
FY2024 Q2$7.9M
$7.9M
Q2
FY2024 Q3$11.6M
$11.6M
Q3
FY2024 Q4$23.6M
$23.6M
Q4
FY2025 Q1$20.4M
$20.4M
Q1
FY2025 Q2$46.3M
$46.3M
Q2
FY2025 Q3$72.3M
$72.3M
Q3
FY2025 Q4$106.5M
$106.5M
Q4
FY2026 Q1$36.2M
$36.2M
Q1
Actual
+$15.8M (+77.5%)

Net Income

$37.9M
FY2024 Q2$-36.5M
$-36.5M
Q2
FY2024 Q3$-69.8M
$-69.8M
Q3
FY2024 Q4$-105.5M
$-105.5M
Q4
FY2025 Q1$-3.1M
$-3.1M
Q1
FY2025 Q2$71.6M
$71.6M
Q2
FY2025 Q3$71.1M
$71.1M
Q3
FY2025 Q4$83.2M
$83.2M
Q4
FY2026 Q1$37.9M
$37.9M
Q1
Actual
+$41M (+1322.7%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$13.3M
Est:$12.9M
FY2020BEAT
$13.3M
FY2021BEAT
Actual:$28.6M
Est:$28.3M
FY2021BEAT
$28.6M
FY2022MISS
Actual:$10.2M
Est:$11.2M
FY2022MISS
$10.2M
FY2023BEAT
Actual:$27.5M
Est:$23.7M
FY2023BEAT
$27.5M
FY2024BEAT
Actual:$23.6M
Est:$20.5M
FY2024BEAT
$23.6M
FY2025BEAT
Actual:$106.5M
Est:$100.4M
FY2025BEAT
$106.5M

Analyst Estimates